I do call out some posts as "delusional." For exa

I do call out some posts as "delusional." For example, when the CEO says ESS is worth around $100M and Redspeed make claims that is worth $1.8B.

Regenicin was never valued that high. It went public and immediately tanked in value. I owned it.

That $1.8B number is puffery from a contingency fee lawyer's complaint.

Quote:

---

ESS was tied up in a $1.643B lawsuit for years until Amarantus unraveled it, but there are folks that would like people to believe it's worthless. Regenicin, the previous owners, were valued at $1.8B before the litigation and a lot of positive events have happened since then. Get this into trial again and value will come back quickly as it's already been proven to work.

---